Pedro Carmo

Pedro Carmo serves as a Senior Alliance Manager at FairJourney Biologics since February 2022, where key achievements include exceeding business development objectives and leading the Alliance Management team from 2024. Carmo has extensive experience in business development, focusing on cell line development, drug discovery, and technology transfer, partnering with international biotech and pharmaceutical companies. Carmo has been a Corporate Sponsor Member of The Antibody Society since January 2023. Previous roles include Research Grant Holder at CESAM, where research focused on the toxicity of nanomaterials, and an Undergraduate Researcher at n9ve, studying the environmental effects of heavy metals. Educational qualifications include a Master of Science in Applied Biology and a Bachelor of Science in Biotechnology from Universidade de Aveiro.